Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Mechanical stimulation and new therapies show promise for hair regrowth.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

Rosa rugosa extract promotes hair growth and could be a natural treatment for hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Pu-erh tea reduces hair loss risk in offspring.

Limosilactobacillus reuteri from honeybees may promote hair growth by activating a specific cell pathway.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.